Top Markets
Coin of the day
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Hisse Senetlerindeki Sıralama #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Hisse Fiyatı
$2.52
Piyasa Değeri
$274.65M
Değişim (1 gün)
0.46%
Değişim (1 yıl)
-56.11%
Ülke
CN
Ticaret VISEN Pharmaceuticals (2561)

Kategori

VISEN Pharmaceuticals (2561) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $2.51 - 2026-09-01

Gün sonu en düşük fiyat: $7.66 - 2025-03-01
VISEN Pharmaceuticals için hisse fiyatı geçmişi: 2025 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -15.85%
2025 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.63%
IN
$215.70 26.53%
CH